{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:16:53Z","timestamp":1783189013519,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023670","name":"The Key Find","doi-asserted-by":"publisher","award":["OLL-779081"],"award-info":[{"award-number":["OLL-779081"]}],"id":[{"id":"10.13039\/501100023670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023670","name":"The Key Find","doi-asserted-by":"publisher","award":["OLL-878311"],"award-info":[{"award-number":["OLL-878311"]}],"id":[{"id":"10.13039\/501100023670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009228","name":"\u00d6rebro County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Brain Foundation","doi-asserted-by":"publisher","award":["FO2019-0094"],"award-info":[{"award-number":["FO2019-0094"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Foundation","doi-asserted-by":"publisher","award":["M84\/19"],"award-info":[{"award-number":["M84\/19"]}],"id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbih.2026.101270","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:56:40Z","timestamp":1779926200000},"page":"101270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Th1\/Th17-linked transcription factors TBX21 and RORC were associated with clinical response to rituximab in treatment-resistant schizophrenia"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1003-3749","authenticated-orcid":false,"given":"Simon","family":"Bylund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats B.","family":"Humble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Bejerot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Wikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.bbih.2026.101270_bib1","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1017\/S0033291719001995","article-title":"An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis","volume":"49","author":"\u00c7akici","year":"2019","journal-title":"Psychol. Med."},{"issue":"8","key":"10.1016\/j.bbih.2026.101270_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","article-title":"Inflammation in the neurocircuitry of obsessive-compulsive disorder","volume":"74","author":"Attwells","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbih.2026.101270_bib3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101270_bib4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1186\/s12888-023-05250-5","article-title":"Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits)","volume":"23","author":"Bejerot","year":"2023","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.bbih.2026.101270_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13256-018-1929-z","article-title":"Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report","volume":"13","author":"Bejerot","year":"2019","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.bbih.2026.101270_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jpsychires.2022.12.003","article-title":"Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: two open-label pilot studies on treatment-resistant patients","volume":"158","author":"Bejerot","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbih.2026.101270_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2017.08.001","article-title":"Th17 cells in depression","volume":"69","author":"Beurel","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.bbih.2026.101270_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/diagnostics10110926","article-title":"Type 17 immune response facilitates progression of inflammation and correlates with cognition in stable schizophrenia","volume":"10","author":"Borovcanin","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.bbih.2026.101270_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.943869","article-title":"A cross-sectional study on associations between BDNF, CRP, IL-6 and clinical symptoms, cognitive and personal performance in patients with paranoid schizophrenia","volume":"13","author":"Chumakov","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.bbih.2026.101270_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neubiorev.2021.03.004","article-title":"Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia","volume":"125","author":"Corsi-Zuelli","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"17","key":"10.1016\/j.bbih.2026.101270_bib11","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.3390\/jcm10173849","article-title":"The role of cytokines in the pathogenesis of schizophrenia","volume":"10","author":"Dawidowski","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbih.2026.101270_bib12","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/schbul\/sbu049","article-title":"Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications","volume":"40","author":"Debnath","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbih.2026.101270_bib13","article-title":"Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications","volume":"2016","author":"Dos Passos","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"25","key":"10.1016\/j.bbih.2026.101270_bib14","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bbih.2026.101270_bib15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/npp.2017.258","article-title":"A randomized, double-blind, placebo-controlled clinical trial of tocilizumab, an interleukin-6 receptor antibody, for residual symptoms in schizophrenia","volume":"43","author":"Girgis","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.bbih.2026.101270_bib16","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbih.2026.101270_bib17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale\u2013brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbih.2026.101270_bib18","series-title":"ECDEU Assessment Manual for Psychopharmacology, Revised","author":"Guy","year":"1976"},{"issue":"9","key":"10.1016\/j.bbih.2026.101270_bib19","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/epi.17327","article-title":"Second-line immunotherapy and functional outcomes in autoimmune encephalitis: a systematic review and individual patient data meta-analysis","volume":"63","author":"Halliday","year":"2022","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.bbih.2026.101270_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbih.2026.101270_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing\u2013remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbih.2026.101270_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761920","article-title":"Expression regulation and function of T-Bet in NK cells","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbih.2026.101270_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107757","article-title":"Commentary on: \"IUPHAR review - novel therapeutic targets for schizophrenia treatment: a translational perspective\"","volume":"216","author":"Humble","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbih.2026.101270_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2025.08.006","article-title":"Aquaporin-4 positive extracellular vesicles and cytokines in cerebrospinal fluid in schizophrenia and obsessive-compulsive disorder, and associations with peripheral cytokines","volume":"284","author":"Humble","year":"2025","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbih.2026.101270_bib25","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood\u2013brain barrier disruption","volume":"24","author":"Huppert","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbih.2026.101270_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbih.2026.101270_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jri.2018.02.006","article-title":"Immune profile in relation to sex steroid cyclicity in healthy women and women with multiple sclerosis","volume":"126","author":"Kempe","year":"2018","journal-title":"J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.bbih.2026.101270_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbih.2026.101270_bib29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.pnpbp.2004.05.047","article-title":"Th1, Th2 and Th3 cytokine alteration in schizophrenia","volume":"28","author":"Kim","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbih.2026.101270_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.24408","article-title":"Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis","volume":"78","author":"Komori","year":"2015","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.bbih.2026.101270_bib31","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/phar.2887","article-title":"A systematic review of clozapine-associated inflammation and related monitoring","volume":"43","author":"Leung","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.bbih.2026.101270_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00406-016-0669-6","article-title":"Social cognition and metacognition in obsessive-compulsive disorder: an explorative pilot study","volume":"266","author":"Mavrogiorgou","year":"2016","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.bbih.2026.101270_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2025.104629","article-title":"The role of neuroinflammation in schizophrenia: focus on Th17 cells functions","volume":"110","author":"Melnikov","year":"2025","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.bbih.2026.101270_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157339510791823673","article-title":"Immune system and schizophrenia","volume":"6","author":"M\u00fcller","year":"2010","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.bbih.2026.101270_bib35","first-page":"323","article-title":"Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning: the personal and social performance scale (PSP)","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.bbih.2026.101270_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/YIC.0000000000000399","article-title":"Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial","volume":"37","author":"Motamed","year":"2022","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbih.2026.101270_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11011-025-01548-3","article-title":"Impact of neuroinflammation on brain glutamate and dopamine signalling in schizophrenia: an update","volume":"40","author":"Nayak","year":"2025","journal-title":"Metab. Brain Dis."},{"issue":"5","key":"10.1016\/j.bbih.2026.101270_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/ane.13291","article-title":"Efficacy and safety of rituximab in autoimmune encephalitis: a meta-analysis","volume":"142","author":"Nepal","year":"2020","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.bbih.2026.101270_bib39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.euroneuro.2018.12.008","article-title":"Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic na\u00efve first episode psychosis","volume":"29","author":"Noto","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbih.2026.101270_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/1570159X16666180119144538","article-title":"Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review","volume":"16","author":"Orsolini","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.bbih.2026.101270_bib41","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.pnpbp.2005.11.028","article-title":"Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines","volume":"30","author":"Pallanti","year":"2006","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"issue":"9","key":"10.1016\/j.bbih.2026.101270_bib42","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s12276-025-01535-9","article-title":"Th17 cell pathogenicity in autoimmune disease","volume":"57","author":"Park","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"7510","key":"10.1016\/j.bbih.2026.101270_bib43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbih.2026.101270_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.2021.61","article-title":"Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis","volume":"220","author":"Siskind","year":"2022","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbih.2026.101270_bib45","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/brain\/awy069","article-title":"T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention","volume":"141","author":"van Langelaar","year":"2018","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.bbih.2026.101270_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbi.2023.10.012","article-title":"Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: a randomized control trial","volume":"115","author":"Weickert","year":"2024","journal-title":"Brain Behav. Immun."}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:31:25Z","timestamp":1783186285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354626001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"alternative-id":["S2666354626001031"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101270","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Th1\/Th17-linked transcription factors TBX21 and RORC were associated with clinical response to rituximab in treatment-resistant schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101270"}}